152054
Tobacco use and cessation in substance abuse treatment settings: A policy review
Tuesday, November 6, 2007
Meredith Silverstein, PhD
,
Colorado Social Research Associates, Denver, CO
Nancy VanDeMark, PhD
,
Colorado Social Reserach Associates, Denver, CO
Ellen Brown, PhD
,
Colorado Social Research Associates, Denver, CO
Bill Wendt, JD
,
Signal Behavioral Health Network, Denver, CO
A 2006 survey of tobacco use among clients and staff within Signal Behavioral Health Network(“Signal”), a managed services organization providing publicly funded substance abuse treatment in 35 Colorado counties, found that 80% (N= 635) of clients and 29% (N=76) of staff surveyed currently smoke. Yet little was known about the tobacco policies of these network providers. Signal contracted with Colorado Social Research Associates to conduct a policy analysis under its Tobacco Use Recovery Now (TURN) program. The purpose of the analysis was to describe the range of current tobacco use policies among provider members, to determine gaps in these policies, and to facilitate effective policy development promoting tobacco cessation and control network-wide. Sixteen of Signal's 17 providers participated in this study. A blended qualitative and quantitative methodological approach established seven domains examining policies' scope, stated purpose, communication requirements, and provisions for tobacco cessation regarding both clients and staff across providers. Recommendations on definitions, content, and the larger context of policies within substance abuse treatment agencies and their treatment philosophies are discussed.
Learning Objectives: At the conclusion of this session the participant (learner) will be able to:
1.Analyze common themes of tobacco control policies within substance abuse treatment providers.
2.Identify key elements of these policies and gaps that may exist.
3.Discuss how to develop and integrate comprehensive tobacco control policies within treatment settings.
Keywords: Tobacco Policy, Substance Abuse Treatment
Presenting author's disclosure statement:Any relevant financial relationships? No Any institutionally-contracted trials related to this submission?
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|